UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
0
By
In Artificial Intelligence, biology, Biotech, biotechnology, cambridge, Disease, drug discovery, Europe, Fundings & Exits, genomics, Health, Life Sciences, Mogrify, stem cell, TechCrunch - Funding & Exits, Technology News, United Kingdom
Posted

UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon

Cambridge, UK-based biotech startup Mogrify, which is working on systematizing the development of novel cell therapies in areas such as regenerative medicine, has closed an initial $16 million [...]

READ MORE
 Biofourmis raises $35M to develop smarter treatments for chronic diseases
0
By
In Artificial Intelligence, Asia, Aviva Ventures, Biofourmis, blogs, boston, ceo, China, Co-founder, digital media, Disease, fda, Funding, Fundings & Exits, Health, healthcare, insurance, MassMutual Ventures, openspace ventures, PillPack, Sequoia, Singapore, TechCrunch, TechCrunch - Funding & Exits, Technology News, United States, Verizon Media, websites, world wide web
Posted

Biofourmis raises $35M to develop smarter treatments for chronic diseases

Biofourmis, a Singapore-based startup pioneering a distinctly tech-based approach to the treatment of chronic conditions, has raised a $35 million Series B round for expansion. The round was led [...]

READ MORE
 RDMD attacks rare diseases with data mined from health records
0
By
In Apps, Bio, Biotech, Disease, electronic medical records, First Round Capital, Flatiron Health, Funding, Fundings & Exits, Health, healthcare, Kevin Weil, lux capital, Medical Records, Recent Funding, Science, shasta ventures, Startups, TC, TechCrunch - Funding & Exits, Technology News, Village Global
Posted

RDMD attacks rare diseases with data mined from health records

You wouldn’t expect a medical app to get its start as a Snapchat competitor. Neither did video chat startup TapTalk’s founder Onno Faber. But four years ago he was diagnosed with [...]

READ MORE